BioSpace News Archive

BioMidwest

Wesana Health to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th

Wesana Health Holdings Inc. today announced that Daniel Carcillo, CEO of Wesana Health, will participate in the KCSA Psychedelics Investor Conference to be held at VirtualInvestorConferences.com on October 13-14, 2021.

October 11, 2021
·
7 min read
Business

Reneo Pharmaceuticals Appoints Ashley Hall as Chief Development Officer

Reneo Pharmaceuticals, Inc. today announced the appointment of Ashley F. Hall, JD, to the position of Chief Development Officer.

October 11, 2021
·
4 min read
Business

Nautilus Biotechnology to Announce Third Quarter of Fiscal Year 2021 Financial Results on November 2, 2021

Nautilus Biotechnology, Inc. today announced it will report financial results for the third quarter of fiscal year 2021 before market open on Tuesday, November 2nd, 2021.

October 11, 2021
·
1 min read
Pharm Country

Athenex Provides Update from FDA Type A Meeting Regarding Oral Paclitaxel + Encequidar in Metastatic Breast Cancer

Athenex today announced that it recently held a Type A meeting with the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for oral paclitaxel and encequidar (Oral Paclitaxel) in metastatic breast cancer (mBC).

October 11, 2021
·
4 min read
Biotech Bay

Aligos Therapeutics Begins Dosing with Antisense Oligonucleotide Drug Candidate, ALG-020572, in Healthy Volunteers in a Phase 1 Proof-of-Concept Study

Aligos Therapeutics, Inc. today announced that the company has started dosing in the first cohort of healthy volunteers in Study ALG-020572-401 (NCT05001022).

October 11, 2021
·
5 min read
Drug Development

Reistone Announces Positive Results from a Phase II Study Evaluating SHR0302 Ointment for Patients with Mild-to-Moderate Atopic Dermatitis

Reistone Biopharma today announced positive results from a Phase II study evaluating the safety and efficacy of twice daily SHR0302 ointment in adults and adolescents with mild-to-moderate atopic dermatitis (AD).

October 11, 2021
·
4 min read
Drug Development

INOVIO Expands INNOVATE Phase 3 for INO-4800, its DNA Vaccine Candidate for COVID-19, to include Colombia following Regulatory Authorization

Authorization to conduct INNOVATE Phase 3 in Colombia builds on recent regulatory authorizations from Brazil, Philippines, and Mexico

October 11, 2021
·
7 min read
Business

Minerva Neurosciences Announces Promotion of Geoff Race to President

Minerva Neurosciences, Inc. today announced that Geoff Race, current Executive Vice President, Chief Financial Officer and Chief Business Officer of Minerva, has been promoted to President.

October 11, 2021
·
5 min read
Drug Development

SCYNEXIS Announces Preclinical Data at the 10th Trends in Medical Mycology Meeting Supporting Potential of Ibrexafungerp to Treat Mucormycosis

SCYNEXIS, Inc. today announced the presentation of preclinical data supporting the potential of its broad-spectrum antifungal, ibrexafungerp, to treat mucormycosis.

October 11, 2021
·
6 min read
Business

AXIM® Biotechnologies Appoints Leading US Ophthalmic Surgeon and Researcher Dr. Henry D. Perry to its Medical Advisory BoardDr. Perry is Third World-Class Ophthalmologist to Join the Advisory Board

AXIM Biotechnologies, Inc. today announced it has appointed Henry D. Perry, MD to its recently established Medical Advisory Board.

October 11, 2021
·
5 min read